- Category
- Small (2024-25)
- Udyam number
- UDYAM-UP-29-0053732

Glenford Pharmaceuticals Private Limited
About Glenford Pharmaceuticals Private Limited
Data last updated:
Glenford Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2019PTC357636. Its GSTIN is 09AAICG0809N1ZA (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mohit Saini and Munish Kumar Jain.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1/6464 2nd Floor East Rohtash Nagar, New Delhi, Delhi, India – 110032.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.91 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹9.09 Lakh (net margin 1.3%) and EBITDA of ₹23.78 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years.
As per MCA filings, the company has open charges of ₹77 Lakh on record. Court records list 12 cases involving the company, including 11 filed by the company and 1 filed against it; 9 cases are pending.
Glenford Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0053732).
Company details
Recognitions & Rankings of Glenford Pharmaceuticals
Contact details
Glenford Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1/6464 2nd Floor East Rohtash Nagar, New Delhi, Delhi, India – 110032
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Glenford Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Glenford Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Glenford Pharmaceuticals Private Limited, buy the company report.
Financials of Glenford Pharmaceuticals Private Limited
FY 2024 filings availableGlenford Pharmaceuticals Private Limited reported revenue of ₹6.91 Cr (up 21% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 26% over three years, including 21% growth in the latest year. EBITDA rose 58% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.78 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.09 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Glenford Pharmaceuticals Private Limited, buy the company report.
Board of directors of Glenford Pharmaceuticals Private Limited
Glenford Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohit Saini | Director | 02 Mar 2021 | 5 Years 8 Months | Current |
| Munish Kumar Jain | Additional Director | 17 Nov 2025 | 1 Years 0 Months | Current |
Peer comparison
Glenford Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Azesto Impex Private Limited | ₹6.94 Cr (FY 2019) | 13.0% | Nagpur, Maharashtra, India | |||
| Neospan Pharma Care Private Limited | ₹6.91 Cr (FY 2024) | 15.0% | Chennai, Tamil Nadu, India | |||
| Glenford Pharmaceuticals Private Limitedthis company | ₹6.91 Cr (FY 2025) | ₹9.09 Lakh | 1.3% | 21.0% | New Delhi, Delhi, India | |
| Sai Kripa Trading Private Limited | ₹6.9 Cr (FY 2025) | 46.0% | Raipur, Chhattisgarh, India | |||
| Vasuchem Lifesciences Private Limited | ₹6.9 Cr (FY 2025) | 38.0% | Pune, Maharashtra, India | |||
| Zelleven Healthcare Private Limited | ₹6.88 Cr (FY 2024) | 8.0% | New Delhi, Delhi, India | |||
| Quality Nexgen Pharmaceuticals Private Limited | ₹6.88 Cr (FY 2022) | -42.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Glenford Pharmaceuticals Private Limited, buy the company report.
Auditor
Glenford Pharmaceuticals Private Limited is audited by TUSHAR TAYAL AND ASSOCIATES. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| TUSHAR TAYAL AND ASSOCIATES. | FY 2023 | 028428C |
Shareholding
The shareholding of Glenford Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Glenford Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Jan 2024 | 100855530 | Hdfc Bank Limited | ₹77 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Glenford Pharmaceuticals Private Limited has 12 court cases on record: 11 filed by Glenford Pharmaceuticals, 1 filed against it. 9 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 12 | 1 | 9 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Shahdara, Delhi | Commercial suit | Filed against the company by Johnlee Pharmaceuticals Private Limited and Anr | Disposed |
| District court, East, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed by the company against M/S Shree Sai Surgical | Pending |
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed by the company against M/S Shri Bhawani | Pending |
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed by the company against M/S Maheshwati Pharma | Pending |
To see the full case history of Glenford Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glenford Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Glenford Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICG0809N1ZA | Uttar Pradesh | Active | 27 May 2021 |
To see the full GST registrations and return filing status of Glenford Pharmaceuticals Private Limited, buy the company report.
Recent activity
Glenford Pharmaceuticals Private Limited has 5 board changes on record since 2019: 3 appointments and 2 cessations. The latest: Munish Kumar Jain was appointed as Additional Director on 17 Nov 2025.
Frequently asked questions
Glenford Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 November 2019 (7+ years old) and is registered under CIN U51909DL2019PTC357636.
Glenford Pharmaceuticals has 2 current directors:
- Mohit Saini - Director
- Munish Kumar Jain - Additional Director
The latest financial statements of Glenford Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Glenford Pharmaceuticals is 09AAICG0809N1ZA, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Glenford Pharmaceuticals is U51909DL2019PTC357636. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glenford Pharmaceuticals has 12 court cases on record: 11 filed by the company and 1 filed against it. 9 are pending.
Glenford Pharmaceuticals was incorporated on 18 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Glenford Pharmaceuticals by revenue are Azesto Impex Private Limited, Neospan Pharma Care Private Limited, Sai Kripa Trading Private Limited, Vasuchem Lifesciences Private Limited, Zelleven Healthcare Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Munish Kumar Jain was appointed as Additional Director on 17 Nov 2025. Munish Kumar Jain ceased to be Director on 10 Oct 2022. Mohit Saini ceased to be Additional Director on 30 Nov 2021. Glenford Pharmaceuticals has 5 board changes on record in total.
Yes, Glenford Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-UP-29-0053732).
The registered office of Glenford Pharmaceuticals is at 16464 2nd Floor East Rohtash Nagar, New Delhi, Delhi, India – 110032.

